• Users Online: 97
  • Print this page
  • Email this page
HEALTH POLICY ANALYSIS AND PERSPECTIVE
Year : 2019  |  Volume : 2  |  Issue : 4  |  Page : 109-114

Implementation of country-wide pharmacoeconomic principles in cancer care in developing countries: Expert-based recommendations


1 King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; Department of Oncology, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
2 Department of Applied Health Research, University College London, London, United Kingdom
3 Department of Health Economics, Corvinus University Budapest, Budapest, Hungary
4 College of Pharmacy, Al Ain University, Al Ain, United Arab Emirates
5 College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Global Academy for Health Sciences, Cincinnati, Ohio, USA
6 Pharmacy Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
7 King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Drug Policy and Economic Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
8 Department of Pharmacy, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
9 Comparative Outcomes Group, Bristol, United Kingdom

Correspondence Address:
Abdul Rahman Jazieh
Department of Oncology, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, P.O. Box 22490, Riyadh 11426.
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/JQSH.JQSH_11_19

Get Permissions

Introduction: Cancer care is a major challenge to health care and for optimal outcomes, health systems need to align policy across many areas of public life. The recognition that even the wealthiest nations can fail optimum outcomes indicates a need for increased efficiency in cancer control programs. Fundamental to this is the efficient direction of resources––a process that can be optimized through economic measures. This article contains expert recommendations on how decision makers can implement pharmacoeconomic principles at national level in developing countries. Methods: A multidisciplinary panel of 10 experts was formed of oncologists, clinical pharmacists, health economists, and chronic disease control and public health experts from different countries and health-care sectors. The panel developed consensus recommendations for different stakeholders using a framework analysis method. Results: Recommendations were categorized as national level, hospital level, industry level, and public-community level to support decision makers in implementing pharmacoeconomic principles in a systematic way. The recommendations included having proper well-structured, data-driven processes with a specific role for each stakeholder. We proposed required structures and processes in such a way that they can be customized based on individual country plans. Conclusion: The expert panel recommendations will serve as a guide to relevant stakeholders at a national level. Adaptation of these recommendations to each setting is important to accommodate the situation and needs of each country.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1296    
    Printed51    
    Emailed0    
    PDF Downloaded38    
    Comments [Add]    

Recommend this journal